Jonathan Barratt
Company: University of Leicester
Job title: Professor, Renal Medicine & Consultant Nephrologist
Seminars:
Unpacking KDIGO’s Updated Clinical Practice Guidelines: Implications for IgAN Drug Development 8:30 am
Examine the critical updates in KDIGO’s recommendations Discuss how the guidelines’ shifts the clinical trial landscape, influencing the design of future trials and the search for novel therapeutic targets Explore how KDIGO's updated treatment and diagnostic standards may affect regulatory approvals, reimbursement policies, and market access for IgAN therapiesRead more
day: Pre-Conference Focus Day
Breakfast Briefing – Understanding Physicians & Primary Care Givers Perspectives 7:40 am
The Breakfast Briefings at the CKD summit is designed to foster open and insightful conversations in an intimate setting, providing a unique opportunity for attendees to interact with top physicians, researchers, primary care givers and patient advocates. In these roundtable discussions, experts will share their personal experiences, insights, and practical knowledge on key challenges and…Read more
day: Day Two AM
Fireside Chat: Navigating the Multi-Drug Treatment Landscape in CKD: Understanding the Implications on Drug Discovery & Development to Inform Future Directions 8:00 am
As the chronic kidney disease treatment landscape evolves, marked by significant breakthroughs such as SGLT2i, GLP-1s, ACEi/ARBs, MRAs, the field is rapidly advancing toward more effective multi-drug therapies. However, these advancements present new challenges and considerations for drug discovery, development, and clinical trial design. This panel will explore the complexities of leveraging these successes to…Read more
day: Day One AM
Panel Discussion & Audience Roundtable: Advancing Therapeutics in Glomerular Diseases: What’s Next? 2:30 pm
Discuss the need to identify reliable surrogate markers for other glomerular diseases and potential avenues for development and standardization Discuss what can be learned from the established biomarkers in IgA nephropathy to improve patient outcomes in other glomerular diseases Examine the variability in pathology and clinical presentation among glomerular disease patients, and what strategies can…Read more
day: Pre-Conference Focus Day
Panel Discussion: IgA Nephropathy: Current Achievements, Unmet Needs, & Research Priorities 8:30 am
Explore a comprehensive overview of breakthroughs in IgAN therapies that improve renal outcomes. How far have we come in slowing disease progression and reducing proteinuria? Despite advancements, where do gaps still persist? Distil the limitations of existing therapies, variability in patient responses, and the challenges of predicting long-term outcomes. What hurdles remain for patients and…Read more
day: Pre-Conference Focus Day